Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1988;21(2):163-7.
doi: 10.1007/BF00257365.

Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose

Affiliations
Comparative Study

Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose

G Daugaard et al. Cancer Chemother Pharmacol. 1988.

Abstract

To investigate the effect of high-dose cisplatin (40 mg/m2 daily for 5 days), 51Cr-EDTA clearance was used as a measure of glomerular filtration rate (GFR). 51Cr-EDTA clearance decreased significantly from 109 +/- 3 ml/min * 1.73 m2 to 68 +/- 3 ml/min * 1.73 m2 after three cycles of cisplatin and remained at this decreased level during the observation period (24 months). To determine the reliability of creatinine as a measure of GFR, we compared the simultaneous clearance of creatinine to that of 51Cr-EDTA. A good correlation between 51Cr-EDTA clearance and creatinine clearance was observed before and 3 months after termination of treatment, but no correlation was found during treatment. S-creatinine decreased significantly during treatment, probably due to muscle wasting. We conclude that s-creatinine and creatinine clearance are unsuitable measures of glomerular function during high-dose cisplatin treatment. All patients developed proteinuria during treatment. The changes in clearance ratios of beta-2-microglobulin/albumin and IgG/albumin show that the proteinuria observed during cisplatin infusion is predominantly of tubular origin, whereas the proteinuria between the treatment periods is mainly of glomerular origin.

PubMed Disclaimer

References

    1. Clin Chim Acta. 1972 Oct;41:209-17 - PubMed
    1. Cancer. 1983 Jun 1;51(11):2035-40 - PubMed
    1. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1083-6 - PubMed
    1. Clin Physiol. 1981 Aug;1(4):417-25 - PubMed
    1. J Clin Invest. 1969 Jul;48(7):1189-98 - PubMed

Publication types

LinkOut - more resources